Fingerprint
Dive into the research topics of 'Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
Lisa Zimmer, Susmitha Apuri, Zeynep Eroglu, Lisa A. Kottschade, Andrea Forschner, Ralf Gutzmer, Max Schlaak, Lucie Heinzerling, Angela M. Krackhardt, Carmen Loquai, Svetomir N. Markovic, Richard W. Joseph, Kelly Markey, Jochen S. Utikal, Carsten Weishaupt, Simone M. Goldinger, Vernon K. Sondak, Jonathan S. Zager, Dirk Schadendorf, Nikhil I. Khushalani
Research output: Contribution to journal › Article › peer-review
84
Scopus
citations